Cencora (COR) Surpasses Q1 Earnings and Revenue Estimates

Core Insights - Cencora reported quarterly earnings of $3.73 per share, exceeding the Zacks Consensus Estimate of $3.50 per share, and showing an increase from $3.28 per share a year ago, resulting in an earnings surprise of 6.57% [1] - The company achieved revenues of $81.49 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 4.31% and up from $72.25 billion year-over-year [2] - Cencora's stock has increased approximately 12% since the beginning of the year, outperforming the S&P 500's gain of 2.7% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.25 on revenues of $75 billion, while for the current fiscal year, the estimate is $15.14 on revenues of $320.36 billion [7] - The estimate revisions trend for Cencora is favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical Services industry, to which Cencora belongs, is currently ranked in the bottom 30% of over 250 Zacks industries, which may impact stock performance [8] - Medpace, another company in the same industry, is expected to report quarterly earnings of $2.97 per share, reflecting a year-over-year increase of 20.7%, with revenues projected at $536.37 million, up 7.6% from the previous year [9][10]